TP53 and Miyoshi myopathy: TP53 mutations and copy number loss are associated with disease progression and increased drug resistance in MM patients.2,38 We further evaluated the synergistic efficacy of the combination in RPMI-8226 xenograft mouse model (TP53 E285K, function loss).